Experts in many corners of Penn Medicine are at work combatting the deadly toll of the opioid epidemic, including the physicians and researchers of the Center for Health Incentives and Behavioral Economics (CHIBE) at the Perelman School of Medicine.
Survivors of opioid overdose have a higher risk of death than individuals who have not experienced an overdose. Effective strategies to lower that risk are critically important to combatting the opioid epidemic in the United States.
Medications to treat opioid use disorder (OUD) are one potential strategy, but research about the effect of medication use on survival after an overdose is limited. To address that gap, a team led by researchers from the Boston University CTSI reviewed medical records for more than 17,500 adults who had survived an opioid overdose.
On Saturday, June 2, over 100 researchers, doctors and public health professionals gathered at the University of Rochester Medical Center to discuss how to best address the opioid crisis through translational science and research. Attendees from more than 40 institutions, agencies and companies from across the country discussed a variety of opioid-related topics, forged new partnerships and collaborations, and developed ideas to tackle the crisis.
Posted: June 11, 2018
It’s one of the largest, most wide-spread public health crises our country and our community has ever faced. The incidence rate of heroin and prescription opioid abuse and related deaths has reached epidemic proportions. On today’s show, we’ll explore how this concerning problem is affecting members of our community, and how it’s impacting medical education and practice.It’s a special report on collaboration to battle our community’s opioid abuse crisis, inside this edition of CTSI Discovery Radio
The Clinical & Translational Science Institute of Southeast Wisconsin (CTSI) is pleased to announce our Request for Applications for 2019 Traditional Pilot Awards as part of the Pilot Translational & Clinical Studies Program.
